Pharmaceutical

Almirall completes EU regulatory procedure for antifungal Jublia

Almirall has completed the decentralised regulatory procedure in Europe for efinaconazole to treat onychomycosis.

Oct 16, 2024 - 04:00
Almirall completes EU regulatory procedure for antifungal Jublia
Almirall has completed the decentralised regulatory procedure in Europe for efinaconazole to treat onychomycosis.
Read the original article

Tags:

Previous Article

The science of viscous drug product filling: Pumps, pressure, and process optimi...

Next Article

Parenteral Solutions in Contract Manufacturing for the Pharmaceutical Industry 

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

South Korean company Dong-A ST wins FDA approval for Stelara biosimilar

South Korean company Dong-A ST wins FDA approval for St...

Oct 12, 2024

Caris and Merck KGaA link to develop ADCs for cancer treatment

Caris and Merck KGaA link to develop ADCs for cancer tr...

Apr 7, 2024

Evotec shuts down gene therapy business in light of Q1 2024 loss 

Evotec shuts down gene therapy business in light of Q1 ...

May 23, 2024